MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$19,836K
Cash and cash
equivalents
$6,452K
Prepaid expenses and
other current assets
$2,914K
Intangible assets
$67,726K
Total current assets
$29,202K
Other assets
$11,874K
Property and equipment,
net
$616K
Operating lease
right-of-use assets
$481K
Total assets
$109,899K
Total liabilities and
stockholders equity
$109,899K
Total liabilities
$108,840K
Total stockholders
equity
$1,059K
Accumulated deficit
-$420,993K
Long-term contingent
consideration
$61,213K
Total current
liabilities
$26,044K
Warrant liabilities
$14,853K
Deferred tax liabilities
$5,593K
Other long-term
liabilities
$778K
Long-term operating lease
liabilities
$359K
Additional paid in capital
$415,705K
Accumulated other
comprehensive income (loss)
$6,293K
Common stock, 0.001 par
value, 250,000,000...
$54K
Current portion of debt
$17,520K
Accrued expenses and
other current...
$5,121K
Accounts payable
$3,403K
Back
Back
Balance Sheet
source: myfinsight.com
Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc. (QNCX)